Periodykse koartsBernesûnensLab-útslach
PFAPA-syndroom kin weromkommende hege koartsen feroarsaakje mei mûleswierkes, seare kiel en opsette halsklieren, dy't ornaris 3–7 dagen duorje, mei folslein herstel tusken de oanfallen. De diagnoaze hinget ôf fan it werhelle patroan en it útsluten fan oare oarsaken—net fan ien ôfwikende bloedtest. In symptoomdeiboek helpt; in ûngewoan swiere of oare ôflevering freget om in nije beoardieling.
Medysk beoardiele troch Thomas Klein, MD
Wichtichste punten
- PFAPA-syndroom feroarsaket ornaris koartsepisoaden dy't 3–7 dagen duorje, mei ferskate wiken fan goede sûnens tusken de episoaden.
- PFAPA-symptomen omfetsje afteuze mûleswierkes, faryngitis en opsette halslymfeklieren; net alle 3 skaaimerken hoege tagelyk foar te kommen.
- Koartspatroan folget faak in rûge syklus fan 2–8 wiken, mar krekte regelmjittigens op 'e kalinder is net fereaske foar de diagnoaze.
- Symptoomdeiboeken moatte de datums fan episoaden, de maksimale temperatuer yn °C of °F, symptomen, medisinen en herstel tusken oanfallen fêstlizze.
- Bloedûndersiken kin by oanfallen in ferhege CRP en neutrofilen sjen litte; in CRP fan 80 mg/L makket gjin ûnderskied tusken PFAPA en in ynfeksje.
- Sykliske neutropeny kin sawat elke 21 dagen weromkomme en kinne opienfolgjende bloedtellings fereaskje ynstee fan ien gerêststellende CBC.
- Behannelbesluten kinne troch in dokter foarskreaune kortikosteroïden, previnsjemedisinen of tonsillektomy omfetsje; neat dêrfan moat allinnich op grûn fan in laboratoariumresultaat dien wurde.
- Dringende beoardieling is nedich foar elke poppe jonger as 3 moannen mei in temperatuer fan 38°C of heger, of elk bern mei sykheljenproblemen, fermindere reäksjefermogen of in útslach dy't net ferdwynt by druk.
Wat is PFAPA-syndroom, en wat feroarsaket de koartsen?
PFAPA-syndroom is in autoinflammatoire tastân dy't werhelle koartsoanfallen feroarsaket mei afteuze mûleswieren, faryngitis en cervicale adenitis. Oanfallen duorje ornaris 3–7 dagen; bern krije tusken de ôfleveringen meastal har gewoane enerzjy, appetit en groei werom.

PFAPA wjerspegelet in ûnpassende aktivearring fan inflammatoire paden, ynstee fan in nije besmetlike sykte dy't elke pear wiken opdûkt. It begjint meast foar de leeftyd fan 5 jier, mar âldere bern en folwoeksenen kinne it ek krije; de histoaryske leeftydsgrins is dêrom in oanwizing, gjin absolute útsluting (Wang et al., 2021). PFAPA betsjut net dat elke takomstige koarts net-besmetlik is.
It akronym beskriuwt 4 ûnderdielen: periodike koarts, afteuze stomatitis, faryngitis en adenitis. Oars as by ferskate erflike periodike koartssykten is der foar PFAPA gjin inkele fêststelde genetyske test dy't de diagnoaze befêstiget, hoewol't it yn famyljes faker foarkomme kin; in negatyf breed genetysk panel bewiist PFAPA net en slút ek net alle oare inflammatoire steurnissen út.
Kantesti is in AI bloedtestanalysator dy't helpe kin te ferklearjen wêrom't in CRP-resultaat fan 80 mg/L klinyske kontekst nedich hat ynstee fan in diagnostysk etiket. Us organisaasje en oanpak beskriuwe de tsjinst, mar foar it fêststellen fan PFAPA moat in dokter symptomen oer meardere ôfleveringen mei-inoar ferbine, it bern ûndersykje en tastannen beskôgje dy't in laboratoariumrapport net sjen litte kin.
Hokker PFAPA-symptomen meitsje it patroan werkenber?
PFAPA-symptomen geane meastal gear mei koarts en keelpine, teare halsklieren of lytse mûleswieren. Deselde kombinaasje dy't weromkomt oer 3 of mear dokumintearre ôfleveringen is ynformativer as elk apart symptoom, hoewol't der gjin universeel minimumtal ôfleveringen is dat PFAPA befêstiget.

Afteuze swieren binne meastal lytse, ûndjippe searjes oan 'e binnenkant fan 'e lippen, wangen of oare oerflakken yn 'e mûle—net itselde as groepkes blierren oan 'e bûtenkant fan 'e lip. In bern kin mar 1 of 2 searjes hawwe, en by guon oanfallen kinne swieren ûntbrekke; in foto meitsje fan in sichtbere searje kin helpe as dy foar de ôfspraak ferdwynt.
Faryngitis kin readens of in laach op 'e tonsillen omfetsje, dus op basis fan it uterlik allinnich kin PFAPA net fan in streptokokkeynfeksje ûnderskieden wurde. Swollen klieren sitte meastal by de cervicale lymfeklieren om 'e hals, wylst in klier dy't oanhâldend grutter wurdt, algemiene klierfergrutting of symptomen dy't langer as in oanfal fan 3–7 dagen duorje in oare ferklearring nedich hawwe ynstee fan automatysk oan PFAPA taskreaun te wurden.
Mûleswieren allinnich binne gjin diagnoaze fan periodike koarts. Weromkommende mûleswieren tegearre mei genitale swieren, pynlike reade eagen, fisusferoaringen of ûngewoane hûdfynsten wize op oare mooglikheden, ynklusyf symptoompatroanen by sykte fan Behçet; sels 1 ôflevering fan eachpine mei beheind sicht freget om in rappe beoardieling, sûnder te wachtsjen op in nije koartssyklus.
Hoe lang duorje PFAPA-koartsen, en hoe faak komme se werom?
PFAPA-koartsen duorje ornaris 3–7 dagen en komme sawat elke 2–8 wiken, werom, faak mei opfallend ferlykbere symptomen. Guon bern krije in foarsisber ritme, mar wikseljende tuskenskoften slute PFAPA net automatysk út.

Temperatures during PFAPA attacks often reach 39–40°C, but fever height does not determine the diagnosis or reliably measure danger. The timing of associated throat symptoms, the child's appearance and the return to baseline matter more; measuring temperature with the same method also makes comparisons more useful than alternating between forehead, ear and underarm readings.
For a hypothetical child, fevers beginning on days 1, 29 and 58 with 4-day attacks suggest a repeated cycle—not proof of PFAPA. Count start-to-start intervals separately from fever-free days, and record whether corticosteroid treatment changed an interval; a shortened next cycle after treatment can otherwise make a previously regular pattern look inexplicably irregular.
A fever that does not stop is not a series of separate PFAPA episodes. If symptoms persist beyond 7 days, or recovery never occurs, clinicians reconsider infection and other inflammatory conditions; our explanation of effekten fan it momint fan bloedôfname also shows why a sample taken on day 1 cannot be interpreted like one taken after recovery.
Wat moat in PFAPA-symptoomdeiboek fêstlizze?
A PFAPA symptom diary should record episode start and finish dates, measured temperature, mouth and throat findings, neck swelling, medication timing and wellness between attacks. Even 3 carefully documented episodes can reveal details that a single clinic visit misses.

Document the thermometer method and the highest measured temperature, not just 'very hot.' For each day of a 4-day attack, note drinking, urine output, activity, cough, runny nose, abdominal symptoms and whether anyone nearby was ill; these observations distinguish a repeated inflammatory pattern from unrelated respiratory or gastrointestinal illnesses more effectively than recording fever alone.
Medication entries need the name, dose, administration time and observed response. If a prescribed medicine is given at 09:00 and fever settles by 14:00, record that interval without claiming the medicine established PFAPA; include throat swab results and whether a laboratory sample preceded treatment, because both antibiotics and corticosteroids can complicate interpretation of subsequent findings.
Well days deserve entries too. A weekly note of normal appetite, play, school attendance and any lingering symptoms prevents a diary from becoming an attack-only record; when a clinician requests a recovery sample, our tarieding op mjittingen yn rêst explains how to record recent illness and medicines rather than treating a sample 2 days after fever as an unquestionable baseline.
Wêrom is it sa wichtich dat men tusken PFAPA-episoaden sûn is?
Complete wellness between episodes strongly supports a typical PFAPA pattern: normal activity, appetite and growth should return after the 3–7-day attack. Persistent symptoms or continuing inflammation between attacks make clinicians reconsider the diagnosis.

A child who is fever-free but remains exhausted, loses weight or develops daily pain has not truly returned to baseline. Growth is assessed through serial height and weight measurements, not 1 percentile in isolation; crossing growth centiles over time may justify investigation even when individual fever episodes resemble PFAPA and routine examinations during attacks look familiar.
Repeated ordinary infections are common in young children, but unusually severe, prolonged or unusual infections suggest a different evaluation. A history of 2 hospital-treated infections or recurrent deep infections matters differently from several mild colds; clinicians consider the organisms, sites, treatment response and family history, as discussed in our guide to testjen faak ynfeksjes.
Inflammatory markers usually fall toward the laboratory reference range between PFAPA attacks, but an immediately post-fever sample may still reflect recovery. A persistent CRP of 25 mg/L on repeated genuinely well-day samples is not proof of another disease, yet it deserves explanation; a clinician may check for an unnoticed infection, ongoing inflammatory symptoms or a sampling timeline that was mislabeled.
Wat litte CRP, ESR en bloedtellingen sjen by PFAPA?
PFAPA attacks can raise CRP, ESR and neutrophil counts, but none of these tests confirms PFAPA or excludes infection. Many laboratories use a CRP upper reference limit around 5 mg/L, wylst oaren brûke 10 mg/L; the report's own range matters.

Consider a hypothetical child with CRP 80 mg/L during fever and 3 mg/L after recovery. That change supports an episodic inflammatory process but does not identify its cause; infection can produce the same pattern, while ESR may normalize more slowly than CRP, making a modestly raised recovery ESR less surprising than persistent symptoms or repeatedly elevated CRP.
White-cell interpretation must use age-appropriate absolute counts rather than adult ranges or percentages alone. At Kantesti, we emphasize that CRP 8 mg/dL equals 80 mg/L—a tenfold unit conversion that can otherwise create a false impression of improvement; our WBC en CRP fergeliking explains why these markers can disagree because they change at different rates.
Procalcitonin is sometimes considered when serious bacterial infection is suspected, but it is not a standalone PFAPA discriminator. A low result, including a value below 0.1 ng/mL, cannot safely overrule a concerning examination or very early illness; the limits described in our gids foar de ynterpretaasje fan procalcitonine matter more than using one reassuring number to justify home treatment.
Hoe stelle klinisy de diagnoaze PFAPA?
PFAPA diagnosis is clinical: clinicians identify repeated characteristic attacks, document recovery between them and exclude plausible alternatives. Onset before age 5 supports traditional criteria, but later onset does not prevent a diagnosis when the overall pattern fits.
The diagnostic process usually starts with history and examination rather than an extensive panel of rare-disease tests. Wang et al. (2021) describe the value of stereotyped episodes, absence of typical respiratory symptoms, negative relevant cultures and response to prescribed corticosteroids; however, 1 negative throat swab or 1 rapid response cannot independently establish PFAPA, and classification criteria are not identical to bedside diagnosis.
Streptococcal testing addresses the current throat illness, while an ASO antibody test mainly reflects previous exposure. An ASO result of 400 IU/mL does not prove that today's recurrent fever is active strep infection; age, local reference ranges and symptom timing affect interpretation, as explained in our discussion of ASO and recent exposure.
Kantesti is in AI-oandreaune ark foar analyse fan bloedtests that can contextualize laboratory units and repeated results, but 2 matching reports cannot confirm PFAPA. Our technysk en klinysk tafersjoch information should not be read as validation of a PFAPA diagnostic test; pediatric or rheumatology assessment remains necessary when the pattern is atypical, severe or uncertain.
Hoe wurdt PFAPA ûnderskieden fan werhelle ynfeksjes?
Repeated infections are more likely when episodes follow sick contacts, have varying symptoms or include cough, runny nose, diarrhea or a confirmed pathogen. PFAPA more often repeats a similar 3–7-day pattern with complete wellness between attacks, but the two can coexist.

A positive respiratory PCR does not always explain the entire fever history. Adenovirus can remain detectable after an illness, so 1 positive result must be matched to current symptoms, examination and timing; our discussion of deteksje en útskieding fan adenofirus explains why a molecular result may indicate recent exposure rather than the cause of every subsequent attack.
Longer-lasting sore throat, fatigue and gland enlargement can suggest a different illness rather than PFAPA. EBV antibody patterns distinguish recent infection from prior exposure more effectively than a single positive IgG result; our EBV antistofpatroan gids explains the roles of 3 commonly reported markers—VCA IgM, VCA IgG and EBNA IgG—without equating past exposure with today's symptoms.
Antibiotic response is also easy to misread. If an antibiotic begins on day 4 and the fever ends on day 5, spontaneous resolution of a PFAPA attack is possible; conversely, a confirmed bacterial infection still requires appropriate treatment, and neither previous PFAPA nor prior antibiotic failure permits a new illness with different symptoms to be dismissed without assessment.
Hokker oare periodike koartsoandwaningen kinne op PFAPA lykje?
Sykliske neutropeny and inherited autoinflammatory disorders can resemble PFAPA, especially when mouth sores accompany recurring fever. Approximately 21-day cycles, severe infections, marked abdominal or chest pain, unusual rashes or persistent inflammation help clinicians decide which alternatives to investigate.

Cyclic neutropenia can produce recurrent fever, mouth sores and gum problems while a blood count between low-count periods looks normal. When suspected, clinicians may request CBCs 2–3 times weekly for about 6 weeks to identify repeated neutrophil nadirs; an absolute neutrophil count below 0.5 × 10^9/L during fever requires urgent clinical assessment rather than being labeled a routine PFAPA attack.
Familial Mediterranean fever often causes shorter attacks, commonly 12–72 hours, with abdominal or chest pain from serosal inflammation or joint symptoms. Our útlis oer MEFV-testen shows why genotype and symptoms must be interpreted together; TRAPS may produce longer attacks, sometimes over 7 days, while mevalonate kinase deficiency can involve diarrhea, vomiting and attacks triggered by vaccination or other stressors.
Ancestry and family history guide assessment, but neither should become a gatekeeper that excludes an inherited disorder. Persistently raised serum amyloid A between attacks can indicate ongoing inflammation and requires context, as our serum amyloid A guide explains; a single high value during a 4-day fever does not diagnose amyloidosis, and typical PFAPA should not automatically be assigned the complication risks of other syndromes.
Hokker warskôgingstekens by koarts fereaskje driuwende beoardieling?
Sykje spoedsoarch for fever with breathing difficulty, reduced responsiveness, a stiff neck, a non-blanching rash or severe dehydration. An infant younger than 3 moannen mei in temperatuer fan 38°C of heger needs urgent medical assessment, even if a family member has PFAPA.

Difficulty swallowing saliva, drooling, a muffled voice or marked one-sided throat swelling can indicate an airway-threatening problem rather than a usual PFAPA flare. A child aged 3–6 months with a temperature of 39°C or higher also needs urgent assessment; contact local emergency services for immediate danger instead of waiting for a blood result or an expected fever endpoint.
Fever lasting 5 days or longer warrants prompt medical review, particularly with red eyes, cracked lips, rash or swollen hands and feet. These findings can suggest Kawasaki disease, discussed in our Kawasaki assessment guide; incomplete presentations occur, so clinicians do not require every classic feature, and concerning symptoms should be assessed before day 5 rather than waiting for a threshold.
New severe localized abdominal pain, persistent vomiting or inability to walk normally should not be attributed to PFAPA without examination. Even 1 normal WBC or CRP result cannot reliably exclude an early abdominal emergency, as our appendicitis laboratory limits explain; children with a known fever syndrome can still develop unrelated illnesses, especially when the attack looks different from their established pattern.
Hoe wurde PFAPA-oanfallen behannele, en wat betsjut de reaksje op steroïden?
PFAPA attack treatment focuses on comfort, hydration and, when prescribed, corticosteroids that often stop fever within hours. Published prednisone or prednisolone regimens range from 0.5–2 mg/kg, but dosing, maximum dose and eligibility must be set by the treating clinician.

Vanoni et al. (2016) describe rapid corticosteroid responses alongside the limitation that treatment may shorten the interval to the next attack. Reports summarized in that review estimated shorter intervals in approximately 25–50% of patients, but these observations come from heterogeneous studies rather than a precise prediction for an individual child; attack control and long-term prevention are separate treatment goals.
For a hypothetical 20-kg child, a clinician-selected dose of 1 mg/kg would equal 20 mg; this calculation illustrates weight-based prescribing, not a home-treatment recommendation. Families need a written plan explaining when a familiar attack qualifies for treatment, when to seek assessment first and what to do if the expected response does not occur—especially if symptoms suggest a new infection.
Antipyretics may improve discomfort even when they do not end the inflammatory episode. Choose child-appropriate preparations with a clinician or pharmacist, avoid aspirin unless specifically prescribed and do not duplicate paracetamol/acetaminophen across 2 products; Kantesti cannot authorize steroid treatment, and our discussion of AI-ynterpretaasje by bern explains why pediatric decisions need more than laboratory pattern recognition.
Wannear wurde previntive medisinen of in tonsillektomy beskôge?
Prevention or tonsillectomy may be considered when PFAPA attacks repeatedly disrupt daily life or attack treatment is unsatisfactory. A Cochrane review included 2 randomized trials involving 67 children, finding benefit from tonsil surgery while emphasizing the limited size of the evidence base.

Burton et al. (2019) judged the evidence for several tonsillectomy outcomes to be of moderate certainty, but the trials were too small to characterize uncommon harms confidently. The evidence concerns selected children rather than every person with recurrent sore throat; a child missing 4 school days each month may value potential benefit differently from a child with infrequent, easily managed attacks.
Colchicine is sometimes used to reduce attacks under specialist supervision, whereas cimetidine has less convincing evidence. Treatment selection should consider the diagnosis, kidney and liver function, other medicines and the possibility of an inherited fever disorder; when several options exist, agree in advance on a measurable goal, such as fewer attacks across 3 months, rather than assuming a changed laboratory number demonstrates success.
Tonsillectomy carries postoperative pain, dehydration, anesthesia-related risks and bleeding risk, even when it improves PFAPA. Kantesti's rjochtlinen foar ferantwurde AI supports a clear boundary: neither 1 elevated inflammatory marker nor an automated report can decide whether surgery is appropriate; that discussion belongs with the treating pediatric team and an ENT specialist who can assess the child's individual risks.
Hokker neisoarch helpt bern, folwoeksenen en famyljes mei PFAPA?
PFAPA follow-up should track attack burden, growth or weight, treatment response and any symptoms between episodes. Many childhood cases improve over several years, but persistence, relapse and adult-onset disease occur; a 3-month review interval can be a practical individualized plan rather than a universal rule.

Adults require the same attention to repeated patterns and alternative causes, not an assumption that PFAPA is impossible after childhood. Fever with oral sores and pharyngitis can support the diagnosis, but new constitutional symptoms, persistent gland enlargement or abnormal findings between attacks need assessment; a 35-year-old with a first prolonged fever should not self-diagnose PFAPA from an online symptom match.
Prepare a concise appointment summary: attack dates, duration, associated features, well-day symptoms, test results and response to prescribed treatment. Include 1 clearly labeled attack sample and any clinician-requested recovery sample, rather than ordering a broad panel every month; repeated testing is useful only when it answers a specific question, such as whether inflammation persists or neutrophil counts cycle.
Kantesti is in AI bloedtest-útslachplatfoarm that can help explain uploaded CBC and inflammatory-marker reports alongside their dates, units and stated reference ranges. For a family sharing 2 or more records, check each person's identity and consent before upload, and review our privacy en gegevensôfhanneling; AI explanation does not replace pediatric examination, urgent triage or a specialist diagnosis.
Undersykspublikaasjes: bewiis tsjin eftergrûnynformaasje oer laboratoariumtests
PFAPA evidence comes from clinical descriptions, differential-diagnosis research and treatment studies—not from a specific clotting or serum-protein test. The 2 background publications below explain other laboratory topics and should not be mistaken for studies validating PFAPA diagnosis.

The peer-reviewed PFAPA review by Wang et al. (2021), treatment review by Vanoni et al. (2016) and Cochrane analysis by Burton et al. (2019) directly inform this article's clinical discussion. The surgical review's 67-child evidence base illustrates why certainty must be proportionate to study size; a named source supports a specific claim, not every recommendation made elsewhere on the page.
De clotting test background guide en eftergrûngids oer serumproteïnen accompany the 2 Zenodo records listed below. Neither aPTT nor an albumin/globulin ratio confirms PFAPA, and neither guide establishes that routine testing of those markers improves PFAPA care; additional tests should follow an identified clinical concern rather than the availability of a panel.
Evidence interpretation should distinguish a repository-hosted educational guide from a peer-reviewed condition-specific study or systematic review. Our medyske ynhâldsnoarmen explain the editorial approach; for a child with 3 apparently similar attacks, the practical priority remains documented recovery, targeted exclusion of alternatives and a clear safety plan, not accumulating more citations or tests that do not answer the clinical question.
Faak stelde fragen
Wat is it PFAPA-syndroom?
PFAPA-syndroom is in autoinflammatoire oandwaning dy't weromkommende koarts feroarsaket, mei aftes yn 'e mûle, faryngitis en opsette lymfeklieren yn 'e hals. Oanfallen duorje ornaris 3–7 dagen en komme om de pear wiken werom, mei in normale sûnens tusken de oanfallen troch. De oandwaning begjint meastal foar de leeftyd fan 5 jier, hoewol't ek âldere bern en folwoeksenen der lêst fan hawwe kinne. Gjin inkelde bloedtest kin PFAPA befêstigje; de diagnoaze is dêrom basearre op it weromkommende klinyske patroan en it ûndersyk nei oare mooglike oarsaken.
Hoe faak komme PFAPA-koarts oanfallen foar?
PFAPA-koartsen komme ornaris sawat alle 2–8 wiken werom, en yndividuele oanfallen duorje meastal 3–7 dagen. Guon bern hawwe tige regelmjittige syklusen, wylst by oaren de tuskenskoften fariearje. Behanneling mei kortikosteroïden kin de tiid oant de folgjende ôflevering ferkoartsje, dus it tiidstip fan medisinen heart yn it koartssjoernaal. By in oanhâldende koarts of as it bern tusken de oanfallen troch net better wurdt, is opnij beoardieljen nedich; gean der net samar fan út dat dit by PFAPA heart.
Kin in hege CRP-bloedtest PFAPA fêststelle?
In hege CRP-útslach kin gjin PFAPA fêststelle, om't ynfeksjes en oare ûntstekkingssteurnissen deselde ferheging feroarsaakje kinne. Bygelyks, in CRP fan 80 mg/L by koarts en 3 mg/L nei it herstel past by episoadyske ûntstekking, mar jout de oarsaak dêrfan net oan. In protte laboratoaria brûke in boppegrins foar de CRP-referinsjewearde fan om de 5 mg/L, wylst guon 10 mg/L brûke. Klinisy beoardielje de útslach yn kombinaasje mei de symptomen, it ûndersyk, it momint fan de ôfnamme en eventuele relevante ynfeksjetests.
Is PFAPA besmetlik, en binne der antibiotika foar nedich?
PFAPA sels is net besmetlik, en antibiotika behannelje it ûnderlizzende ûntstekkingsproses net. In typyske oanfal fan 3–7 dagen kin fansels ophâlde neidat der mei antibiotika begûn is, wêrtroch de misliedende yndruk ûntstiet dat de antibiotika wurke hawwe. Bern mei PFAPA kinne noch altyd besmetlike firussykten of baktearjele ynfeksjes krije. In nije koarts mei oare symptomen, kontakt mei sike minsken of in befêstige baktearjele oarsaak moat op eigen merites beoardiele en behannele wurde.
Bewiist in snelle reaksje op prednison PFAPA?
In rappe reaksje op foarskreaun prednison of prednisolon stipet PFAPA, mar bewiist de diagnoaze net. Publisearre PFAPA-behannelingsskema’s omfetsje 0,5–2 mg/kg; de werklike doasis en de maksimumdoasis wurde bepaald troch de behanneljend dokter. Kortikosteroïden kinne symptomen fan oare oandwaningen ûnderdrukke en kinne it ynterfal oant de folgjende PFAPA-oanfal ferkoartsje. Famyljes moatte in skriftlik behannelplan brûke en foar de behanneling in beoardieling freegje as in ôflevering ûngewoan earnstich of oars is.
Wanne moat in bern mei in fermoeden fan PFAPA driuwende medyske soarch krije?
In bern mei in fertinking op PFAPA hat needsoarch nedich by koarts mei sykhelproblemen, minder reagearjen, in stive nekke, in útslach dy’t net ferdwynt as jo derop drukke of slimme útdroeging. Elke poppe jonger as 3 moannen mei in temperatuer fan 38°C of heger moat driuwend medysk ûndersocht wurde. Koarts dy’t 5 dagen of langer duorret, freget ek om in rappe beoardieling, foaral as der reade eagen, útslach, gebarsten lippen of swollen hannen en fuotten by binne. In eardere diagnoaze fan PFAPA is gjin reden om in nije sykte mei oare symptomen te negearjen.
Lit jo bloedtest resultaten útlizze
Laad jo laboratoariumrapport op en de AI fan Kantesti leit elke biomarker binnen sekonden út yn gewoane taal. Brûkt troch mear as 2 miljoen minsken wrâldwiid.
Referinsjes
- Klein, T., Mitchell, S., & Weber, H. (2026). aPTT Normaalberik: Gids foar D-Dimer, Protein C en bloedstolling. Kantesti AI Medysk Undersyk. DOI
- Klein, T., Mitchell, S., & Weber, H. (2026). Gids foar serumproteïnen: Globulinen, albumine en de A/G-ferhâlding yn in bloedtest. Kantesti AI Medysk Undersyk. DOI
- Wang A et al. (2021). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A review. World Journal of Otorhinolaryngology - Head and Neck Surgery. DOI
- Vanoni F et al. (2016). PFAPA syndrome: a review on treatment and outcome. Pediatric Rheumatology. DOI
- Burton MJ et al. (2019). Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). Cochrane Database of Systematic Reviews. DOI
- 2M+Analysearre tests
- 127+Lannen
- 100+Talen
Oer it medyske team

Thomas Klein, dokter
Haadauteur · Medyske beoardieler
Haadmedysk Offisier, Kantesti AI
Dr. Thomas Klein is in sertifisearre klinysk hematolooch en ynternist mei mear as 15 jier ûnderfining yn laboratoariummedisinen en AI-assistearre klinyske analyze.

Sarah Mitchell, MD, PhD
Medysk adviseur
Haadmedysk adviseur - Klinyske patology en ynterne medisinen
Dr. Sarah Mitchell is in board-sertifisearre klinysk patolooch mei mear as 18 jier ûnderfining yn laboratoariummedisinen en diagnostyske analyse. Se hat spesjalistyske sertifikaasjes yn klinyske skiekunde en hat wiidweidich publisearre oer biomarkerpanielen en laboratoariumanalyse yn de klinyske praktyk.

Prof. Dr. Hans Weber, PhD
Bydragende ekspert
Heechlearaar Laboratoariumgeneeskunde en Klinyske Biogemy
Prof. Dr. Hans Weber bringt 30+ jier ekspertize yn klinyske biogemy, laboratoariummedisinen, en biomarkerûndersyk. Eardere presidint fan de Dútske Genoatskip foar Klinyske Skiekunde, hy spesjalisearret him yn analyse fan diagnostyske panielen, standerdisearring fan biomerkers, en AI-oandreaune laboratoariummedisinen.
E-E-A-T fertrouwensignalen
Ûnderfining
Dokter-oandreaune klinyske resinsje fan lab-ynterpretaasje-wurkprosessen.
Ekspertize
Fokus fan laboratoariummedisyne op hoe’t biomarkers har gedrage yn in klinyske kontekst.
Autoriteit
Medysk beoardiele troch Dr. Thomas Klein, mei bydragen fan Dr. Sarah Mitchell en prof. dr. Hans Weber.
Betrouberens
Bewiis-basearre ynterpretaasje mei dúdlike ferfolchpaadkes om alarm te ferminderjen.
Lês fierder
Mear medyske hantliedingen fan de Kantesti medysk team:

Genetyske testen foar Ehlers-Danlos: detektearbere typen en beheiningen
Genetyske testen foar Ehlers-Danlos kinne in protte subtypen befêstigje, mar net hypermobile EDS. Begryp negative testpanielen, patogene farianten en VUS foardat jo…
Lês it artikel →
Tularemietestresultaten: antistoffen en tiidstip fan diagnoaze
In tularemia-test kin ier betiid negatyf wêze. Untdek wannear't keppele antystofmonsters helpe, hokker oanwizingen foar bleatstelling wichtich binne en wannear't…
Lês it artikel →
AlloSure-testresultaten: ôfstotingsrisiko, ôfsnijwearden en beheiningen
Begryp de testresultaten fan AlloSure, orgaanspesifike ôfkapwearden en oprinnende trends. Sjoch wêrom’t in hege donorôfkomstige DNA-wearde op graftskea wiist en wannear’t in biopsie…
Lês it artikel →
Beta-2-transferrine-test: heldere ôffier en lekkage fan harsensrêchflier
Trochsichtich focht út 'e noas of it ear is net altyd in lekkage fan CSF. Lês wat de beta-2-transferrinetest opspoart, hoe't…
Lês it artikel →
Symptomen fan methanolfersmoarging: timing en warskôgingstekens foar needgefallen
Symptomen fan methanolferskealiging kinne oeren op har wachtsje litte. Wazich sjen is in needgefal. Sykje daliks medyske help nei fertochte bleatstelling; doch…
Lês it artikel →
Analyse fan pleurafloeistof: de kritearia fan Light en folgjende stappen
Begryp de analyze fan pleurafloeistof, de kritearia fan Light, diuretyk-relatearre pseudo-ekssudaten en testen dy't de folgjende stappen bepale. Sjoch hoe’t keppele resultaten ynterpretearre wurde.
Lês it artikel →Untdek al ús sûnensgidsen en AI-oandreaune ark foar bloedtestanalyse by kantesti.net
Medyske disclaimer
Dit artikel is allinnich foar ûnderwiisdoelen en foarmet gjin medysk advys. Rieplachtsje altyd in kwalifisearre soarchferliener foar besluten oer diagnoaze en behanneling.
Publisearre · Nim kontakt op mei it redaksjeteam
Publisearre troch Kantesti Ltd, registrearre yn Ingelân en Wales, bedriuwsnûmer. 17090423, Londen, Feriene Keninkryk.